Clin2
NCT02421718Possibly a fitRecruiting

Follow-up program for lung cancer and related conditions after radiation

Lung Cancer

Part of Cancer, Lungs & breathing clinical trials.

This trial studies a standard follow-up plan to help you stay on track after radiation treatment for lung cancers or certain related conditions. It may help your care team monitor symptoms and outcomes in a consistent way.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a lung cancer diagnosis, such as non-small cell lung cancer, small cell lung cancer (SCLC), or thymoma
  • Or you have lung metastases that were treated with stereotactic (focused) radiation
  • You received a radiation dose higher than 40 Gy
  • You can follow the trial’s follow-up instructions and attend required check-ins

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06410300Recruiting
Heart and lung monitoring during lung cancer radiation and immunotherapy

This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.

Columbia, Missouri
NCT06950073Recruiting
Second radiation treatment for lung cancer in the chest

This study tests whether giving a second course of radiation to the chest (called retreatment) can control lung cancer that has come back or a new cancer that started there. People who have already had radiation to their chest and are healthy enough for more may be eligible.

Aarhus, Jutland
NCT05754203Recruiting
Radiation plus immunotherapy for advanced lung cancer

This trial studies whether a more intensive form of targeted radiation, combined with immunotherapy (immune checkpoint inhibitors), can work better and be safe for people with advanced non-small cell lung cancer. You may be considered if your tumor is limited in size and you’re able to receive both treatments.

Chongqing, Chongqing Municipality
NCT02454790Recruiting
Follow-up program for people with esophageal cancer

This trial tests a standard follow-up plan for people who have esophageal cancer and received a certain amount of radiation. It may help your care team monitor side effects and catch health changes early.

Groningen
NCT06528912Recruiting
Standard Follow-Up Program for Brain Tumor Patients

This trial tests a new follow-up program for people with brain or spinal tumors who are getting radiation therapy. The program aims to improve your care and monitor your recovery after treatment.

Groningen
NCT06429995Enrolling by invitation
Standard follow-up program for breast cancer patients

This trial tests a standard follow-up program for people with breast cancer who are getting radiotherapy. It aims to see how well the program supports patients after treatment.

Groningen

Hear when a new Lung cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.